FIG
REGN icon

Fortress Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Fortress Investment Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-16,510
Closed -$5.95M – 210
2014
Q3 		$5.95M Buy
+16,510
New +$5.53M 0.07% 81
2013
Q4 		– Sell
-9,900
Closed -$3.1M – 183
2013
Q3 		$3.1M Buy
+9,900
New +$2.6M 0.06% 40

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fortress Investment Group's REGN Position: Q4 2014 in Review

Fortress Investment Group sold out of Regeneron Pharmaceuticals (REGN) in Q4 2014, closing a stake of 16,510 shares — an estimated $5.95M sold.

Fortress Investment Group first reported a position in REGN in Q3 2013 and held it in 2 quarters. The position peaked at $5.95M in Q3 2014. 512 funds tracked by Wall St. Rank hold REGN as of Q4 2014.

  • Fortress Investment Group reported no remaining Regeneron Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Fortress Investment Group sold 16,510 Regeneron Pharmaceuticals shares in Q4 2014, an estimated $5.95M.
  • Fortress Investment Group first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • Fortress Investment Group's Regeneron Pharmaceuticals position peaked at $5.95M in Q3 2014.
  • 512 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2014.

Based on Fortress Investment Group's 13F filing for Q4 2014, filed 18 Feb 2015.